Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Public antibodies to malaria antigens generated by two LAIR1 insertion modalities


In two previously described donors, the extracellular domain of LAIR1, a collagen-binding inhibitory receptor encoded on chromosome 19 (ref. 1), was inserted between the V and DJ segments of an antibody. This insertion generated, through somatic mutations, broadly reactive antibodies against RIFINs, a type of variant antigen expressed on the surface of Plasmodium falciparum-infected erythrocytes2. To investigate how frequently such antibodies are produced in response to malaria infection, we screened plasma from two large cohorts of individuals living in malaria-endemic regions. Here we report that 5–10% of malaria-exposed individuals, but none of the European blood donors tested, have high levels of LAIR1-containing antibodies that dominate the response to infected erythrocytes without conferring enhanced protection against febrile malaria. By analysing the antibody-producing B cell clones at the protein, cDNA and gDNA levels, we characterized additional LAIR1 insertions between the V and DJ segments and discovered a second insertion modality whereby the LAIR1 exon encoding the extracellular domain and flanking intronic sequences are inserted into the switch region. By exon shuffling, this mechanism leads to the production of bispecific antibodies in which the LAIR1 domain is precisely positioned at the elbow between the VH and CH1 domains. Additionally, in one donor the genomic DNA encoding the VH and CH1 domains was deleted, leading to the production of a camel-like LAIR1-containing antibody. Sequencing of the switch regions of memory B cells from European blood donors revealed frequent templated inserts originating from transcribed genes that, in rare cases, comprised exons with orientations and frames compatible with expression. These results reveal different modalities of LAIR1 insertion that lead to public and dominant antibodies against infected erythrocytes and suggest that insertion of templated DNA represents an additional mechanism of antibody diversification that can be selected in the immune response against pathogens and exploited for B cell engineering.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Prevalence and dominance of LAIR1-containing antibodies in malaria-endemic regions.
Figure 2: LAIR1-containing antibodies produced by two insertion modalities.
Figure 3: The influence of insert position and somatic mutations on antibody specificity.
Figure 4: Frequent occurrence of templated inserts in the switch region.

Accession codes

Primary accessions



  1. 1

    Meyaard, L. The inhibitory collagen receptor LAIR-1 (CD305). J. Leukoc. Biol. 83, 799–803 (2008)

    CAS  Article  Google Scholar 

  2. 2

    Tan, J. et al. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens. Nature 529, 105–109 (2016)

    CAS  Article  ADS  Google Scholar 

  3. 3

    Mwakasungula, S. et al. Red blood cell indices and prevalence of hemoglobinopathies and glucose 6 phosphate dehydrogenase deficiencies in male Tanzanian residents of Dar es Salaam. Int. J. Mol. Epidemiol. Genet. 5, 185–194 (2014)

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4

    Tran, T. M. et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin. Infect. Dis. 57, 40–47 (2013)

    CAS  Article  Google Scholar 

  5. 5

    Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem. 82, 775–797 (2013)

    CAS  Article  Google Scholar 

  6. 6

    Piccoli, L. et al. Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis. Nat. Commun. 6, 7375 (2015)

    Article  ADS  Google Scholar 

  7. 7

    Reed, J. H., Jackson, J., Christ, D. & Goodnow, C. C. Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunization. J. Exp. Med. 213, 1255–1265 (2016)

    CAS  Article  Google Scholar 

  8. 8

    Long, M., Betrán, E., Thornton, K. & Wang, W. The origin of new genes: glimpses from the young and old. Nat. Rev. Genet. 4, 865–875 (2003)

    CAS  Article  Google Scholar 

  9. 9

    Kolkman, J. A. & Stemmer, W. P. Directed evolution of proteins by exon shuffling. Nat. Biotechnol. 19, 423–428 (2001)

    CAS  Article  Google Scholar 

  10. 10

    Jain, M. et al. Improved data analysis for the MinION nanopore sequencer. Nat. Methods 12, 351–356 (2015)

    CAS  Article  Google Scholar 

  11. 11

    Robbiani, D. F. et al. Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma. Cell 162, 727–737 (2015)

    CAS  Article  Google Scholar 

  12. 12

    Keskin, H. et al. Transcript-RNA-templated DNA recombination and repair. Nature 515, 436–439 (2014)

    CAS  Article  ADS  Google Scholar 

  13. 13

    Chakraborty, A. et al. Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes. Nat. Commun. 7, 13049 (2016)

    CAS  Article  ADS  Google Scholar 

  14. 14

    Onozawa, M. et al. Repair of DNA double-strand breaks by templated nucleotide sequence insertions derived from distant regions of the genome. Proc. Natl Acad. Sci. USA 111, 7729–7734 (2014)

    CAS  Article  ADS  Google Scholar 

  15. 15

    Onozawa, M., Goldberg, L. & Aplan, P. D. Landscape of insertion polymorphisms in the human genome. Genome Biol. Evol. 7, 960–968 (2015)

    CAS  Article  Google Scholar 

  16. 16

    Rommel, P. C., Oliveira, T. Y., Nussenzweig, M. C. & Robbiani, D. F. RAG1/2 induces genomic insertions by mobilizing DNA into RAG1/2-independent breaks. J. Exp. Med. 214, 815–831 (2017)

    CAS  Article  Google Scholar 

  17. 17

    Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673–675 (1976)

    CAS  Article  ADS  Google Scholar 

  18. 18

    Traggiai, E. et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10, 871–875 (2004)

    CAS  Article  Google Scholar 

  19. 19

    Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT–PCR and expression vector cloning. J. Immunol. Methods 329, 112–124 (2008)

    CAS  Article  Google Scholar 

  20. 20

    Lefranc, M.-P. et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37, D1006–D1012 (2009)

    CAS  Article  Google Scholar 

  21. 21

    Goujon, M. et al. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 38, W695–W699 (2010)

    CAS  Article  ADS  Google Scholar 

  22. 22

    Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protocols 9, 171–181 (2014)

    CAS  Article  Google Scholar 

  23. 23

    Mills, F. C., Mitchell, M. P., Harindranath, N. & Max, E. E. Human Ig S gamma regions and their participation in sequential switching to IgE. J. Immunol. 155, 3021–3036 (1995)

    CAS  PubMed  Google Scholar 

  24. 24

    Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at (2013)

  25. 25

    Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012)

    CAS  Article  Google Scholar 

  26. 26

    Neph, S. et al. BEDOPS: high-performance genomic feature operations. Bioinformatics 28, 1919–1920 (2012)

    CAS  Article  Google Scholar 

  27. 27

    Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009)

    Article  Google Scholar 

  28. 28

    Haas, B. J. et al. De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis. Nat. Protocols 8, 1494–1512 (2013)

    CAS  Article  Google Scholar 

  29. 29

    Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinformatics 10, 421 (2009)

    Article  Google Scholar 

  30. 30

    Kiełbasa, S. M., Wan, R., Sato, K., Horton, P. & Frith, M. C. Adaptive seeds tame genomic sequence comparison. Genome Res. 21, 487–493 (2011)

    Article  Google Scholar 

  31. 31

    Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639–1645 (2009)

    CAS  Article  Google Scholar 

  32. 32

    Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013)

    Article  Google Scholar 

  33. 33

    Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016)

    CAS  Article  Google Scholar 

Download references


We thank M. Nussenzweig and H. Wardemann for reagents for antibody cloning and expression. This work was supported by the Swiss Vaccine Research Institute and by the Fondazione Aldo e Cele Daccò. The work on the healthy European blood donors was supported by the European Research Council (grant no. 670955 BROADimmune). The Mali study was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. A.L. and F.S. are supported by the Helmut Horten Foundation. This paper is published with the permission of the Director of KEMRI.

Author information




K.P. characterized genomic DNA, analysed the data and wrote the manuscript; J.T. isolated new LAIR1-containing antibodies, analysed the data and wrote the manuscript; L.P. produced mutant antibodies, analysed the data and wrote the manuscript; M.F. performed bioinformatics analysis; S.B. sequenced and expressed antibodies; Y.C. helped with genomic sequencing; C.S.-F. immortalized memory B cells; T.W. helped with MinION sequencing; D.J. performed cell sorting and analysis; M.A. performed protein analysis; A.A. performed P. falciparum culture; F.M.N., S.J., O.K.D., B.T., I.Z., C.D. and P.C.B. provided cohort samples; T.M.T. and P.D.C. provided cohort samples and analysed the relationship between LAIR1-containing antibodies and malaria risk; F.S. provided supervision; A.L. provided overall supervision, analysed the data and wrote the manuscript.

Corresponding author

Correspondence to Antonio Lanzavecchia.

Ethics declarations

Competing interests

A.L. is the scientific founder and shareholder of Humabs BioMed. F.S. is a shareholder of Humabs BioMed.

Additional information

Reviewer Information Nature thanks P. Preiser, M. Wahlgren and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data figures and tables

Extended Data Figure 1 Alignment of gDNA and cDNA sequences of LAIR1-containing antibodies.

Shown is one representative antibody from each donor. a, MGE9 (donor E); b, MGF21 (donor F); c, MGO3 (donor O); d, MGQ4 (donor Q).

Extended Data Figure 2 Genomic sequences of switch regions containing LAIR1 inserts.

Shown is one representative antibody for each donor; a, MMJ5 (donor J); b, MGM5 (donor M); c, MGB47 (donor B). The chromosome coordinates of the insertion sites are indicated in blue and green.

Extended Data Figure 3 Somatically mutated and conserved regions in the LAIR1 domains inserted in the VDJ or in the switch region.

a, Amino acid substitutions in antibodies isolated from different donors and mean R/S ratios at each residue. The mutational analysis takes into consideration the germline LAIR1 alleles found in each donor. In donor C, the P98L substitution is uncoloured because it may arise from polymorphism, since the donor is heterozygous at this position. The number of nucleotide mutations and amino acid substitutions are reported in brackets next to the antibody names. b, Graphic representation of mutational hot spots (red) and of most conserved regions (blue).

Extended Data Figure 4 Validation of switch region inserts combining Illumina and MinION technologies.

a, Illumina and MinION workflows. Switch regions of polyclonal naive or IgG/IgA switched B cells were amplified by PCR. For Illumina sequencing, PCR amplicons were fragmented, re-amplified during library preparation and sequenced using the 2 × 300 bp MiSeq system. The bioinformatic analysis included the assembly of contiguous, chimaeric reads. For insert confirmation, independently generated PCR-barcoded primary products were sequenced with MinION technology and analysed with a different bioinformatic approach for long, error-prone MinION reads. b, Multiple identical switch inserts for donor 6 were confirmed in biological replicate experiments with independent technical and analytical setups. Shown are the experimental designs, shared and unique reads in a Venn diagram and an alignment of Illumina and MinION sequences covering the switch insertion sites for two examples (LCP1, RAVER1). c, Shared and unique switch inserts in technical and biological replicate experiments of donor 5.

Extended Data Figure 5 Pipeline for data analysis using the Illumina platform.

Shown is the scheme of the bioinformatics workflow used for the analysis of Illumina sequences.

Extended Data Figure 6 Pipeline for data analysis using the MinION technology.

Shown is the scheme of the bioinformatics workflow used for the analysis.

Extended Data Figure 7 Examples of genes that donate multiple inserts.

Shown is the original position of the inserts donated by PAX5 and EBF1 as well as a list of genes that donated two or more inserts.

Extended Data Figure 8 Examples of potentially functional inserts.

Shown is the alignment of the contig sequence and the genomic region from which the insert was derived, as well as the potential amino acid sequence inserted between the VH and CH1.

Extended Data Figure 9 Relationship between LAIR1-IgG or LAIR1-IgM status and protection from febrile malaria.

Shown is the clinical status of 551 members of the Malian cohort, stratified by LAIR1-containing IgG (a) or LAIR1-containing IgM (b) status, over the years 2012 and 2013. Febrile malaria is defined as parasite density ≥ 2,500 asexual parasites per microlitre of blood and an axillary temperature of ≥ 37.5 °C.

Extended Data Table 1 V gene and insert usage of LAIR1-containing antibodies

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-2 and Supplementary Tables 1-2.

Reporting Summary

Supplementary Table 3

This table contains a list of inserts in the switch region found by Illumina sequencing.

Supplementary Table 4

This table contains a list of inserts in the switch region found by MinION sequencing.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pieper, K., Tan, J., Piccoli, L. et al. Public antibodies to malaria antigens generated by two LAIR1 insertion modalities. Nature 548, 597–601 (2017).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing